Waltz health fresenius kabi partner direct payer biosimilar program

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 29 Sept, 21:44 UTC

Digital health company Waltz Health is teaming up with drugmaker Fresenius Kabi to support direct-to-employer efforts for key biosimilar medications.

science

Sources

• T2Waltz health fresenius kabi partner direct payer biosimilar programFierce Biotech / Fierce Healthcare / MedCity / GEN29 Sept, 21:44